Popular Trials
Neuroimaging Techniques Development Related to Addiction
This trial is looking for healthy people to develop new ways to use MRI to study the brain. Eligible participants will be screened with a medical history, physical exam, and blood and urine tests. They will answer questions about their drug use and psychiatric history.
Behavioral Intervention
Specialized Post-Incarceration Care for Opioid Addiction
This trial will compare two different types of care for people who are prescribed medication for opioid use disorder and who are released from detention facilities. 800 people will be followed for a year, and surveys and drug screenings will be used to track their progress.
Popular Filters
Trials for Opioid Use Disorder Patients
Psychedelic Therapy
Psilocybin for Depression
"This trial aims to study the safety and effectiveness of using psilocybin treatment in individuals with psychiatric symptoms that cause functional impairment. The researchers want to see if these individuals will experience a reduction in symptoms
Behavioral Intervention
First Face Training for Mental Health Support in Tribal Communities
This trial evaluates a training program called 'First Face for Mental Health' designed for Tribal community members. The program teaches them how to recognize and help people experiencing mental health crises. The goal is to improve mental health support and reduce stigma within these communities. Mental Health First Aid (MHFA) aims to improve mental health literacy and support for those experiencing mental health issues.
Behavioral Intervention
System Dynamics vs Quality Improvement for Mental Health Care
This trial aims to increase the proportion of patients who start and complete evidence-based care using participatory system dynamics, and to determine the costs of using this method.
Learning Health System Intervention for Substance Use Disorders
This trial seeks to address the national addiction crisis at its epicenter by creating alliances between the juvenile justice system and community mental health centers to disseminate addiction prevention and treatment.
Neurostimulation
Neurostimulation for Addiction
This trial aims to help adults reduce their desire for drugs by using a gentle technique that affects the brain. The goal is to support existing treatments with fewer side effects and better commitment to the treatment plan.
Trials for OUD Patients
Behavioral Intervention
System Dynamics vs Quality Improvement for Mental Health Care
This trial aims to increase the proportion of patients who start and complete evidence-based care using participatory system dynamics, and to determine the costs of using this method.
Learning Health System Intervention for Substance Use Disorders
This trial seeks to address the national addiction crisis at its epicenter by creating alliances between the juvenile justice system and community mental health centers to disseminate addiction prevention and treatment.
Non-invasive Brain Stimulation
tDCS + TUS for Opioid Use Disorder
This trial will study whether transcranial Direct Current Stimulation (tDCS) + Transcranial Ultrasound (TUS) can help treat addiction in people with chronic pain who use opiates. The investigators think active stimulation will be better than fake stimulation.
Phase 3 Trials
Opioid Partial Agonist
Extended Release Buprenorphine for Opioid Use Disorder
This trial is testing whether a 28-day formulation of extended-release buprenorphine is more effective than usual treatment for patients with a moderate or severe opioid use disorder who are seen by an addiction consultation service and agree to start a medication for OUD.
Neuromodulator Medical Device
Bridge Device + Lofexidine for Opioid Use Disorder
This trial is testing a device called the Bridge Device, which uses electrical signals to help people with opioid addiction. The study focuses on individuals who are not currently on any medication for their addiction. The device aims to ease withdrawal symptoms by sending signals to the brain. Participants will be monitored to see if the device effectively reduces withdrawal symptoms.
Opioid Agonist
Buprenorphine for Opioid Addiction during Pregnancy
This trial is testing whether an extended-release form of buprenorphine is as effective as the standard form in treating pregnant women with opioid use disorder, with the goal of improving outcomes for mother and child.
Nicotinic Acetylcholine Receptor Agonist
Cytisine + Video Messaging for Smoking Cessation
This trial, called PREVENT, is studying the effects of cytisine versus a placebo, as well as the effects of video messaging versus standard care, on people who are about to have surgery.
Trials With No Placebo
Psychedelic Therapy
Psilocybin for Depression
"This trial aims to study the safety and effectiveness of using psilocybin treatment in individuals with psychiatric symptoms that cause functional impairment. The researchers want to see if these individuals will experience a reduction in symptoms
Behavioral Intervention
First Face Training for Mental Health Crises
This trial evaluates a training program called First Face for Mental Health, which aims to teach community members how to recognize and respond to mental health crises in youth and adults. The study will involve surveys before and
Behavioral Intervention
First Face Training for Mental Health Support in Tribal Communities
This trial evaluates a training program called 'First Face for Mental Health' designed for Tribal community members. The program teaches them how to recognize and help people experiencing mental health crises. The goal is to improve mental health support and reduce stigma within these communities. Mental Health First Aid (MHFA) aims to improve mental health literacy and support for those experiencing mental health issues.
Behavioral Intervention
System Dynamics vs Quality Improvement for Mental Health Care
This trial aims to increase the proportion of patients who start and complete evidence-based care using participatory system dynamics, and to determine the costs of using this method.
Frequently Asked Questions
Introduction to addiction
What are the top hospitals conducting addiction research?
Addiction is a complex and widespread issue that affects individuals from all walks of life. In the quest to find effective treatments and interventions, some top hospitals are leading the way in conducting clinical trials. One such hospital is the Icahn School of Medicine at Mount Sinai in New york, where dedicated researchers are currently undertaking three active addiction trials. Although they have yet to conduct any past addiction trials, their commitment to advancing understanding and treatment options for addiction is commendable.
In Palo Alto, California, the VA Palo Alto Health Care System also plays a significant role with two ongoing addiction trials. While they haven't conducted any previous addiction studies either, their efforts highlight the importance of addressing addictive disorders among veterans and finding solutions tailored specifically to their needs.
The University of Colorado at Denver similarly demonstrates its dedication to tackling addiction through two active clinical trials. With no prior history of conducting addiction-related studies as well, this institution recognizes that research is essential in developing innovative approaches for better outcomes in fighting addiction.
Meanwhile, Case Western Reserve University stands out in Cleveland with two active clinical trials focused on combating addiction. Like the other hospitals mentioned before them, Case Western has not conducted any past studies on this subject matter but vows to make strides towards understanding addictive behaviors and finding successful interventions.
Lastly,the University of New mexico Family Health Clinic located in North Valley neighborhood within Albuquerque hosts an important presence with its own involvement through current participation into two prominent clinical tests about battling against various forms of addictions.Its novel approach exhibits it's desire towards contribution even without having previous records concerning these issues which brings hope too new possibilities worth exploring by specialist seeking ways impacting broader community diagnosed or affected by addictive tendencies.
These esteemed institutions represent just a few examples among many nationwide striving toward advancements in treating and managing addictions.Additional contributions made through varied investigations carried out across diverse settings provide valuable insights into understanding dependencies while paving way towards more comprehensive solutions ensuring brighter future free from substance abuse related struggles.
Which are the best cities for addiction clinical trials?
In the realm of addiction clinical trials, several cities have emerged as frontrunners in conducting groundbreaking research. Albuquerque, New mexico leads the way with 11 active trials focusing on interventions such as Collaborative Care Plus and Motivational Interviewing at Intake (MII). Following closely behind is New york, New York, with 9 ongoing studies centered on treatments and innovative programs like Communities That HEAL and Behavioral group therapy #1. Toronto, Ontario also stands out with 8 active trials exploring approaches like Integrated Collaborative Care Team (ICCT) and Health Services. These cities collectively offer individuals struggling with addiction valuable opportunities to participate in cutting-edge clinical trials that contribute to improving treatment options for a healthier future.
Which are the top treatments for addiction being explored in clinical trials?
Exciting developments are underway in addiction research, with clinical trials focusing on innovative treatments that show promise. At the forefront is the probiotic treatment, currently undergoing one active trial dedicated to addressing addiction. This groundbreaking approach has already made its mark as the first of its kind listed in 2023 and holds immense potential for transforming how we tackle addiction challenges. As researchers continue their quest for effective interventions, these cutting-edge treatments offer hope for individuals struggling with addiction and pave the way for a brighter future in this field.
What are the most recent clinical trials for addiction?
Recent clinical trials offer hope and potential breakthroughs in addiction treatment. The Aurora 1:1 Drops (Indica) trial, currently in Phase 2, is exploring the effectiveness of this medication for addressing addiction. Another study investigates the use of THC-dominant cannabis as a potential therapeutic option. Additionally, AEF0117 is being evaluated to determine its efficacy in treating addiction. Furthermore, research on transcranial direct current stimulator (tdcs) is advancing our understanding of how this non-invasive technique can be used for addiction therapy. These studies represent significant steps towards improving treatment options and outcomes for individuals battling addiction.
What addiction clinical trials were recently completed?
Several clinical trials focusing on addiction have recently concluded, showcasing notable progress in this critical field. These studies offer insights into innovative and effective approaches for combatting various forms of addiction. One such trial examined the use of a novel medication, sponsored by the University of California San Francisco, to address substance abuse disorders. Additionally, a study led by Yale University explored the effectiveness of cognitive-behavioral therapy combined with pharmacotherapy in treating opioid dependence. These recent advancements underscore the ongoing commitment to finding solutions for individuals battling addiction and hold promise for improved treatment outcomes in the future.